What is hcv infection

Overview

Hepatitis C virus (HCV) infection is a bloodborne viral infection that primarily affects the liver. The virus can cause both acute infection (short-term illness) and chronic infection (long-term disease). With modern antiviral treatments, hepatitis C is now considered a curable disease in most cases.

Transmission

HCV is transmitted through direct blood-to-blood contact. Common transmission routes include:

• Sharing injection equipment for intravenous drug use
• Healthcare worker exposure to infected blood through needlestick injuries
• Blood transfusions and organ transplants before 1992 (before screening was implemented)
• Occupational exposure in healthcare settings
• Less commonly, through sexual contact with an infected partner
• Mother-to-child transmission during childbirth

Acute vs. Chronic Infection

After exposure to HCV, acute infection develops within 2-12 weeks. During acute infection, symptoms may include fatigue, jaundice (yellowing of skin and eyes), abdominal pain, and nausea. However, many people have no symptoms. Approximately 15-45% of people spontaneously clear the virus through their immune system. In the remaining 55-85%, the virus persists, leading to chronic hepatitis C infection.

Symptoms and Complications

Many people with chronic HCV infection have no symptoms for years or decades. When symptoms appear, they may include fatigue, joint pain, depression, and cognitive difficulties. The major concern with chronic HCV is progressive liver damage. Over 20-30 years, chronic infection can lead to cirrhosis (severe liver scarring), liver failure, and hepatocellular carcinoma (liver cancer). The rate of progression varies significantly among individuals based on age, alcohol use, immune status, and other factors.

Diagnosis and Treatment

HCV infection is diagnosed through blood tests detecting HCV antibodies and RNA. Once diagnosed, treatment with direct-acting antiviral (DAA) medications is highly effective, with cure rates exceeding 95%. These oral medications are taken for 8-12 weeks with minimal side effects. Treatment is recommended for all people with hepatitis C, as early treatment prevents serious liver complications.

Prevention

Prevention focuses on avoiding blood contact with infected individuals. Key prevention strategies include using sterile injection equipment, practicing safe needle handling in healthcare settings, and universal precautions. There is currently no vaccine for hepatitis C, though vaccine development is ongoing.